FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

McGuff Compounding Pharmacy Services Thiamine Hydrochloride 3000 mg/30 mL Recall

Thiamine Hydrochloride 3000 mg/30 mL (100mg/mL), Riboflavin 30 mg/30 mL (1mg/mL) Inject…

McGuff Compounding Pharmacy Services, Inc. · Santa Ana, CA

Risk level
Class II
Reported by FDA
Feb 22, 2023
Recall ID
D-0267-2023
Check your lot numberHow we source this data

Summary

McGuff Compounding Pharmacy Services recalled Thiamine Hydrochloride 3000 mg/30 mL starting Dec 8, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0267-2023 on Feb 22, 2023. Reason: Presence of Particulate Matter: Presence of foreign substances were reported in vials at the pharmacy. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: Presence of foreign substances were reported in vials at the pharmacy.

Product description

Thiamine Hydrochloride 3000 mg/30 mL (100mg/mL), Riboflavin 30 mg/30 mL (1mg/mL) Injection, FOR INTRAMUSCULAR OR SLOW INTRAVENOUS USE, 30 mL Sterile Multiple Use Vial, Rx Only, Compounded for a licensed professional or patient use by: McGuff Compounding Pharmacy Services, Inc, Santa Ana, CA 92704.

Lot numbers, UPCs & expiration codes

Lot: 22K1661, initial BUD: 12/18/2022, extended BUD: 1/27/2023; 22J2401, BUD: 12/19/2022.

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0267-2023
Classification
Class II
Status
Terminated
Recall initiated
Dec 8, 2022
FDA report date
Feb 22, 2023
Quantity
255 vials
Recall type
Voluntary: Firm initiated
Recalling firm
McGuff Compounding Pharmacy Services, Inc.

Original FDA data

Every field from FDA enforcement report D-0267-2023, exactly as published.

Show all FDA fields
City
Santa Ana
State
CA
Status
Terminated
Country
United States
Event ID
91498
Address
2921 W Macarthur Blvd Ste 142
Code information
Lot: 22K1661, initial BUD: 12/18/2022, extended BUD: 1/27/2023; 22J2401, BUD: 12/19/2022.
Postal code
92704-7944
Report date
Feb 22, 2023
Product type
Drugs
Recall number
D-0267-2023
Classification
Class II
Recalling firm
McGuff Compounding Pharmacy Services, Inc.
Product quantity
255 vials
Termination date
Apr 27, 2023
Reason for recall
Presence of Particulate Matter: Presence of foreign substances were reported in vials at the pharmacy.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Thiamine Hydrochloride 3000 mg/30 mL (100mg/mL), Riboflavin 30 mg/30 mL (1mg/mL) Injection, FOR INTRAMUSCULAR OR SLOW INTRAVENOUS USE, 30 mL Sterile Multiple Use Vial, Rx Only, Compounded for a licensed professional or patient use by: McGuff Compounding Pharmacy Services, Inc, Santa Ana, CA 92704.
Distribution pattern
Nationwide in the USA
Recall initiation date
Dec 8, 2022
Initial firm notification
Letter
Center classification date
Feb 10, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0267-2023, published Feb 22, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls